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Introduction
Cholera in Haiti: Acute-on-Chronic
Long before the devastating earthquake
on January 12, 2010, Haiti struggled
beneath the burdens of intractable poverty
and ill health. The poorest country in the
Western Hemisphere, Haiti also faces
some of the highest rates of maternal and
infant mortality—widely used indicators of
the robustness of a health system—in the
world ([S1] in Text S1; [2,3]). The
October 2010 cholera outbreak is the
most recent of a long series of affronts to
the health of Haiti’s population; it is yet
another acute symptom of the chronic
weakness of Haiti’s health, water, and
sanitation systems.
Water and sanitation conditions high-
light these systemic weaknesses. In 2002,
Haiti ranked last out of 147 countries for
water security [4,5]. Before the earthquake
struck, only half of the population in the
capital, Port-au-Prince, had access to
latrines or other forms of modern sanita-
tion, and roughly one-third had no access
to tap water [6]. Across the country, access
to sanitation and clean water is even more
limited: only 17% of Haitians had access
to adequate sanitation in 2008, and 12%
received treated water [7]. Not surprising-
ly, diarrheal diseases have long been a
significant cause of death and disability,
especially among children under 5 years of
age [6].
The cholera outbreak began less than a
year after a 7.0-magnitude earthquake
took the lives of more than 300,000 people
and left nearly 1.5 million homeless [6].
Almost 1 million Haitians still live in
spontaneous settlements known as inter-
nally displaced persons (IDP) camps [8].
While post-earthquake conditions in Haiti
were ripe for outbreaks of acute diarrheal
illness, cholera was deemed ‘‘very unlikely
to occur’’ by the United States Centers for
Disease Control and Prevention (CDC)
and other public health authorities [9].
Cholera had never before been reported in
Haiti [S2] [10,11]; health providers were
unprepared for an influx of patients
presenting with acute watery diarrhea.
The cholera epidemic has been most
severe in rural areas and large urban
slums. Rural communities were charged
with hosting hundreds of thousands of
displaced people after the earthquake,
placing greater demands on their al-
ready-scarce resources, including water.
Surface water drawn directly from the
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constitutes the principal supply of drinking
water in rural Haiti. The lack of adequate
piping, filtration, and water treatment
systems (including chlorination) made
these rural regions vulnerable to the rapid
spread of waterborne disease. While most
IDP camps have been supplied with
potable water, large urban slums have
had to rely on existing water sources—
some of them containing Vibrio cholerae—
and have therefore been vulnerable to
rapid disease spread. Most slums also have
poor sanitation infrastructure. Since the
first cases were reported in Saint-Marc
and Mirebalais, cholera has spread to
every department in Haiti, and to other
countries, too [S3] [12–14].
Public suspicion (ultimately validated by
genomic sequence analyses [15]) of the
strain’s link to South Asia, home to a group
of United Nations peacekeepers stationed
in central Haiti, triggered blame and
violence that interfered with response
efforts. As we have learned from the global
AIDS pandemic and other infectious dis-
ease epidemics, cycles of accusation can
continue for years, diverting attention and
resources from the delivery of care and
prevention services [16]. Systemic prob-
lems that brought cholera to epidemic
levels in Haiti will (unless addressed)
continue to facilitate its spread. As a disease
of poverty, cholera preys upon the bottom
of the social gradient; international trade,
migration, and travel—from South Asia or
elsewhere—open direct channels for path-
ogens that follow social fault lines.
The Epidemiology of Cholera in Haiti
V. cholerae is a Gram-negative, rod-
shaped, waterborne bacterium that causes
acute watery diarrhea. A confirmed case
requires laboratory analysis by culture of V.
cholerae. Cholera causes rapid dehydration
and electrolyte imbalances, and leads to
death in up to 50% of untreated cases [17].
Cholera is endemic to Asia and Africa,
with recent outbreaks in Angola, Ethiopia,
Zimbabwe, Pakistan, Somalia, Sudan, and
northern Vietnam. From 1991 to 1994,
Latin America experienced a multi-coun-
try epidemic of more than 1,000,000 cases
and 10,000 deaths. The disease was not
reported in the Caribbean, however, until
the current epidemic in Haiti. While
patients began presenting with severe
watery diarrhea as early as October 13,
2010, the first laboratory-confirmed chol-
era cases (from the Artibonite Depart-
ment) were documented on October 19,
2010 [S4]. Within days, the National
Public Health Laboratory (LNSP) in Haiti
had isolated V. cholerae serogroup O1 of the
El Tor biotype as the cause of these cases
of diarrhea, dehydration, and death [12].
Cholera is expected to be most severe
among immunologically naı ¨ve populations
[18], and the Haitian outbreak exhibited
an initial 7% case-fatality rate—among
the highest recorded rates in recent history
[S5] [18,19]. There were more than 2,000
reported cholera-related deaths in 40 days
[S6] [20]—nearly half the number of total
deaths registered in Zimbabwe’s year-long
epidemic [S7] [21]—and these figures are
likely underreported in many rural areas
[S8] [22].
As of April 4, 2011, the MSPP reported
274,418 cases of cholera and 4,787 deaths
attributed to cholera across all ten of Haiti’s
departments. The overall observed case-
fatality rate was 1.7% [1]. However, cumu-
lative case-fatality rates range from 0.8% to
7.7% across regions (see Table 1), revealing
both the geographic disparities that have
Executive Summary
This joint statement argues for a comprehensive, integrated cholera response in
Haiti. The cholera epidemic in Haiti is particularly devastating because of the
vulnerability of Haiti’s population after the January 12, 2010, earthquake, the
long-standing weakness of its health, water, and sanitation systems, and the
observed virulence of the El Tor hybrid strain. From October 19, 2010—when the
first cases were confirmed in the National Public Health Laboratory—to April 4,
2011, 274,418 cases of cholera and 4,787 deaths related to cholera had been
reported across all ten departments of Haiti [1].
The Haitian Ministe `re de la Sante ´ Publique et de la Population (MSPP, the Ministry
of Health) and the Direction Nationale de l’Eau Potable et de l’Assainissement
(DINEPA, the government body charged with water and sanitation) have, with the
support of many nongovernmental and international groups, made great strides
against cholera. Case-fatality rates have dropped to 2.1% from 7% at the outset of
the epidemic (and up to 10% in certain regions); incidence has also declined
across Haiti, according to recent reports [1]. But fewer cases in the dry season
(November–April) should not lead to complacency: seasonal variation is expected
in epidemics of waterborne disease. Some have raised doubts about the
sustainability of free water distribution within internally displaced persons (IDP)
camps. But we believe that such efforts are an essential service that has
contributed to the relatively few cases of cholera in the camps (as compared to
other urban and rural areas).
Given the likelihood of case resurgence and endemicity of cholera in Haiti, this
document argues for a comprehensive, integrated strategy for cholera prevention
and care in Haiti. We must reduce suffering and preventable death in the short
term, and we must build effective water, sanitation, and health delivery
infrastructure to fortify Haiti against cholera and other diseases of poverty in
the long term.
The document identifies three principal goals. First, we must continue aggressive
case finding and scale up treatment efforts, including oral rehydration therapy,
intravenous rehydration, antibiotic therapy (for moderate and severe cases), and
complementary supplementation with zinc and vitamin A. Second, we must shore
up Haiti’s water infrastructure by building systems for consistent chlorination and
filtration at public water sources and by distributing point-of-use water
purification technologies. We must also strengthen sanitation infrastructure by
improving and expanding waste management facilities (such as sewage systems
and latrines) and waste monitoring. Third, we must link prevention to care by
bolstering surveillance, education campaigns (about hand-washing, for example),
and water, sanitation, and hygiene (WASH) efforts. Prevention must also include
advocacy for scaled-up production of cholera vaccine and the development of a
vaccine strategy for Haiti. A vaccination campaign should be implemented if
adequate vaccine and resources can be mobilized without undermining efforts to
treat acutely ill patients or strengthen water and sanitation infrastructure.
This document identifies key challenges and outlines the components of a
comprehensive cholera response to aid medical and public health practitioners in
Haiti and elsewhere. With leadership from the Haitian government, we must work
together to bolster responses to the acute problem of cholera today and
strengthen Haiti’s health, water, and sanitation infrastructure to prevent similar
outbreaks in the future.
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in cholera care in certain regions [23].
The reduction of case-fatality rates to
under 2% reflects the implementation of
rapid treatment and case management
efforts (Figure 1). Yet as cholera continues
to strain Haiti’s health infrastructure, some
predict an increase in overall mortality
[20]. The majority of cholera-related
deaths occur among patients who do not
reach a hospital in time. Such deaths are
likely underreported in official statistics.
Sustaining the gains made in recent months
will require close surveillance and rapid
treatment if there are case resurgences.
During the first 2 months of the
epidemic, cholera spread most rapidly in
the central and northern parts of the
country [S9] [24]. National elections and
ensuing riots occurred in late November
2010, preventing many patients in Port-
au-Prince from reaching health centers in
time, if at all. The Artibonite Department,
where the first cases were officially docu-
mented, reported the most cases: over
66,000 by April 8, 2011 [23].
Overall incidence in IDP camps has
remained low. (Some camps have reported
mere dozens of cases.) This achievement is
chiefly thanks to the work of the Ministe `re
de la Sante ´ Publique et de la Population
(MSPP), Direction Nationale de l’Eau
Potable et de l’Assainissement (DINEPA),
and many partnering institutions partici-
pating in water, sanitation, and hygiene
(WASH) programs. Such efforts have,
among other things, made safe drinking
water available—mostly for free—to camp-
dwellers. Nonetheless, poor sanitation con-
ditions among the camps could lead to
rapid disease transmission if access to clean
water declines, and recent doubts about the
‘‘sustainability’’ of free water distribution
threaten to undermine such access.
Compared with previous strains of V.
cholerae, some evidence suggests that the hy-
brid El Tor strains in Haiti cause more
asymptomatic cases, persist longer in the
environment, and exist in higher concentra-
tions of bacteria in feces (including in
asymptomatic cases) [S10] [25,26]. Even
though some data suggest a lower ratio of
symptomatic to asymptomatic cases, a
resurgence of cases is likely if surveillance,
prevention, and treatment efforts are not
scaled up.
If past is prologue, there is little reason to
believethatthe‘‘Haitian’’choleraepidemic
will remain strictly Haitian for long. Haiti is
part of a web of global connections, and
pathogens like V. cholerae, HIV, or Mycobac-
terium tuberculosis travel freely throughout
this web. Cases traceable to the Haitian
outbreak have already been reported in the
Dominican Republic, Venezuela, Florida,
and Massachusetts [S11] [12–14]. These
introductions have not led to widespread
disease and are not expected to do so in
areas with adequate water and sanitation
systems. But in other neighboring countries
in the Caribbean and Latin America that
lack these systems, the threat of a multi-
countryepidemic—liketheLatinAmerican
epidemic in the early 1990s—is real.
A Comprehensive, Integrated
Strategy for Cholera Prevention and
Care
A history of poverty, natural disaster,
neglected public water and sanitation sys-
tems,andunder-resourcedhealthinfrastruc-
ture has magnified the impact of cholera in
Haiti. Some have called these conditions a
‘‘perfect storm for a massive epidemic of
cholera’’ [S12] [6]. Responding to cholera
today must address the same long-standing
challenges that have prevented Haiti’s poor
from accessing clean water, adequate food,
and decent health services for decades. An
effective strategy for cholera prevention and
care must continue aggressive case-finding
and treatment efforts, shore up Haiti’s water
and sanitation systems, expand the avail-
ability of prevention services, and coordinate
these cholera-specific interventions to
strengthen Haiti’s health system.
Ongoing efforts led by the Haitian
government and local and international
relief teams have alreadyreduced incidence
and case-fatality rates across the country.
But many medical and public health teams
lack the tools of their trade—including oral
rehydration salts (ORS), intravenous solu-
tion, antibiotics, vaccines, soap, cholera
cots, ambulances—and the rainy season
(May–October) is approaching. We must
move together to marshal the tools needed
to control the epidemic and to fortify Haiti
against cholera for the long term. Divisions
over the respective roles of prevention and
care are as senseless as those over the use
(or lack thereof) of vaccines and antibiotics;
in the face of cholera’s challenge to Haiti
and the world, we can accept nothing less
than complementary and comprehensive
prevention and care.
GOAL 1. Bolster Case Finding
and Treatment
Considering the observed virulence of
this El Tor strain and the fragility of the
Haitian health system, aggressive case
Table 1. Geographic variations in cumulative cases and fatalities (October 20, 2010–April 8, 2011) [24].
Department Total Cases Hospitalized Case Fatalities Non-Hospitalized Case Fatalities Case-Fatality Rate
Artibonite 66,285 568 322 1.3%
Centre 24,782 201 182 1.5%
Grande Anse{ 15,351 343 497 5.3%
Nippes 3,618 62 93 4.2%
Nord{ 27,930 590 45 2.3%
Nord Ouest 16,410 176 72 1.5%
Nord Est 11,833 117 150 2.2%
Ouest* 26,404 255 121 1.4%
Port-au-Prince** 67,579 416 141 0.8%
Sud{ 13,791 181 55 1.7%
Sud Est 3,033 76 172 7.7%
{Excluding Port-au-Prince.
*Incomplete data available.
**Port-au-Prince: Carrefour, Cite ´ Soleil, Delmas, Kenscoff, Petion Ville, Port-au-Prince, et Tabarre.
doi:10.1371/journal.pntd.0001145.t001
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Treatments are inexpensive, effective, and
can be coordinated through existing refer-
ral and communication systems. Although
a network of treatment sites is in place, too
many patients are unable to get the
medical care they need or arrive at cholera
treatment centers in time. Not only do
these individuals face the debilitating
symptoms of cholera (sometimes ending
in death), they continue to spread infec-
tious organisms. We must expand case
finding, patient transport, and treatment
and integrate such efforts into the public
health system to facilitate responses to
future cholera epidemics.
Aggressive Case Finding and
Efficient Transport
Most of the hundreds of thousands of
patients who have received care to date
have not reached cholera treatment sites
as a result of case-finding efforts; they
have fallen ill and been brought in by
their families, sometimes too late [27]. A
mortality assessment by the CDC found
that some patients in the Artibonite
Department died as early as 2 hours
after first exhibiting symptoms [12].
Early in the epidemic, it was estimated
that 40% of cholera-related deaths oc-
curred because patients did not arrive at
treatment sites in time to receive suffi-
cient care (Dr. Jean-William Pape, per-
sonal communication). Even when pa-
tients arrive for care early in the course of
their sickness, many do not receive life-
saving therapeutics like antibiotics due to
limited supplies at treatment sites. Case-
fatality rates of untreated cholera have
been reported as high as 50%, but can be
reduced to 1% with rapid and compre-
hensive treatment, as has been shown in
some parts of Haiti after scaled-up
treatment efforts [25].
However, patient transport and in situ
care remains a bottleneck to scaling up
cholera treatment, especially in rural
areas. Ambulances are in short supply
[27]. With more resources and training,
community health workers could improve
case finding and help overcome delivery
challenges like patient transport.
Making Treatment Substantial: From
ORS to Antibiotics
Treating dehydration—with ORS and
intravenous fluids, both inexpensive and
deliverable in situ—is the key to saving
lives. World Health Organization (WHO)
guidelines provide a framework for man-
aging cholera treatment based on case
severity [28]. Over 80% of cholera
patients can be treated with ORS alone
[28], and yet almost 2 months into the
epidemic, the CDC identified a sizeable
gap in access to ORS [12]. This gap arose
Figure 1. Cholera treatment center, Mirebalais, Haiti, December, 2010. Photo credit: Jonathan L. Weigel, Harvard Medical School and
Partners In Health.
doi:10.1371/journal.pntd.0001145.g001
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diarrhea in Haiti (using ORS and other
interventions effective in treating cholera)
made by the MSPP, Cornell University,
and others. These efforts have helped to
bring down infant mortality rates by about
two-thirds since 1980 [S13] [29–31]. In
recent months, access to ORS has im-
proved significantly, contributing to the
observed decreases in case-fatality rates
countrywide. Nonetheless, ensuring that
ORS is readily available to all populations
at risk of infection, along with developing
ORS stockpiles for future outbreaks,
remains a high priority.
But treatment cannot stop with rehydra-
tion: patients with moderate and severe
disease can still die from persistent fluid loss
while receiving ORS. These patients need
intravenous rehydration and antibiotic
therapy. In addition, innovative therapeu-
tics like rice-based ORS, zinc supplements,
vitamin A, and deworming agents should
be integrated with existing treatment ef-
forts. Most ORS is glucose-based, but some
studies have found rice-based varieties to be
more effective, particularly in reducing
mean stool output [32,33]. This formula-
tion may also improve nutrition. Zinc
supplements have been shown to reduce
the duration of diarrhea, particularly in
children, and are therefore recommended
by the WHO for patients with most
diarrheal diseases, including cholera [S14]
[34–36]. A review of efficacy studies noted
a 23% decrease in diarrhea-related mor-
tality due to zinc treatment [37]. One study
found that zinc treatment for children with
cholera reduced vomiting, diarrhea output
and duration, and hospital stay by 8 hours
[36]. Vitamin A deficiency, sometimes
caused or worsened by diarrheal diseases,
can lead to eye lesions in young children.
The WHO therefore recommends vitamin
A supplements for all individuals with
cholera, especially children [S15] [34].
Deworming agents and childhood vaccina-
tions—readily deliverable in resource-poor
settings and yet rarely available in Haiti—
should also be integrated with cholera
prevention and care. Such piggybacking
interventions could decrease coinfection
with other diseases of poverty that predis-
pose children with cholera to poor treat-
ment outcomes and reduce morbidity,
mortality, and malnutrition among Haiti’s
population [34]. Each of these interven-
tions is part of a comprehensive cholera
care package.
The Case for Antibiotics
Given Haiti’s fragile health system and
the observed virulence of the hybrid El
Tor strain, there is growing consensus
about the urgency of making antibiotic
therapy available for all moderate and
severe cases of cholera (all hospitalized
patients). Policy has shifted in this direc-
tion: most global public health policy-
makers—including the WHO and the Pan
American Health Organization (PAHO),
CDC, MSPP, and the International Cen-
tre for Diarrhoeal Disease Research,
Bangladesh (ICDDR,B)—now recom-
mend antibiotics for all moderate and
severe disease [38,39]. But providers must
be furnished with adequate supplies to
meet these guidelines. To date, too few
patients with moderate disease receive
antibiotic treatment. We must move
rapidly to expand the use of antibiotics
for cholera treatment, which can shorten
the severity and course of illness, reduce
transmission, and lessen the burden on
Haiti’s health system.
First, antibiotics have been shown to
shorten the duration of symptomatic
cholera and therefore limit life-threatening
dehydration. The current strain in circu-
lation in Haiti is susceptible to doxycycline
and azithromycin, resistant to nalidixic
acid and sulfisoxazole (a marker for co-
trimoxazole resistance), and has reduced
susceptibility to ciprofloxacin [12]. Azith-
romycin and doxycycline are effective in
treating severe cholera cases. Azithromy-
cin reduces the duration and volume of
diarrhea and vomiting in strains with
reduced susceptibility to ciprofloxacin
[40]. Broader use of single-dose azithro-
mycin or doxycycline in all hospitalized
patients should be implemented immedi-
ately. Monitoring for antibiotic resistance
on a monthly basis would help ensure that
antibiotic use remains consistent with the
antibiotic sensitivity of the current strain.
Second, antibiotic use brings public
health benefits by reducing transmission.
Antibiotic treatment can cut stool volume
in half [40] and shorten the amount of
time patients shed infectious organisms
from several days to 1 day [40]. Such
organisms exhibit a hyperinfectious quality
5–24 hours after output, elevating the risk
of transmission to those living in city
slums, IDP camps, and households, as
well as others living in close proximity with
cholera patients [41] [18]. In Bangladesh,
it has been shown that 20%–30% of
patients’ household contacts develop
symptoms of cholera within 10–21 days
[42]. Therefore, antibiotics are a pillar of
both prevention and treatment.
Third, expanding access to antibiotic
treatment for all moderate and severe
cases would mitigate the strain on the
health system by decreasing the severity of
illness and duration of inpatient care
(therefore freeing hospital beds for other
patients) [40]. Many treatment sites al-
ready have more patients than beds,
intravenous hydration materials, and other
critical supplies. Reduced demand for
inpatient services would also make re-
sources and staff available for other
components of cholera prevention and
care [S16].
In addition to providing antibiotic
treatment for all moderate and severe
cases, we suggest launching a closely
monitored study about the efficacy of
these drugs for mild cases and for
prophylactic use among certain vulnerable
populations, such as family members,
health care workers, and cellmates of
infected prisoners. Some evidence from
past epidemics in Tanzania and Ecuador
suggests that chemoprophylaxis may lead
to bacterial resistance without compensa-
tory gains in survival [43]. Other experi-
ences indicate that closely monitored
chemoprophylaxis can bring health bene-
fits. For example, one project at the
National Penitentiary of Port-au-Prince
found that providing antibiotics (along
with potable water, soap, and sanitation
services) to prisoners sharing living quar-
ters with cholera patients helped reduce
incidence within the institution [44]. The
risk of resistance means that we should
avoid large-scale chemoprophylaxis cam-
paigns until more research is conducted.
Delivery Challenges to Cholera Care
in Haiti
A triage system of independent treat-
ment sites—cholera treatment centers
(CTCs) and cholera treatment units
(CTUs)—has been deployed in Haiti
[28]. CTCs have an average capacity of
100–400 beds, whereas CTUs tend to
have 15–20 beds and are often attached to
existing health facilities [27]. By providing
emergency care for cholera patients,
CTUs allow hospitals and health centers
to continue delivering normal health
services. In addition, more than 900 oral
rehydration points (ORPs) across the
country help treat patients with mild
disease [S17] [45]. The CTUs and ORPs
serve as a first point of entry into the
health system for individuals with severe
watery diarrhea. Patients are then either
stabilized and sent home or referred to
CTCs [46]. A PAHO bulletin published
on January 23, 2011, reported 85 CTCs
and 129 CTUs throughout the country
[47]. Although some facilities have recent-
ly been closed because of decreasing
disease incidence, they may again be
needed if there is a resurgence of cases in
the coming months and years.
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in both urban and rural Haiti. On the one
hand, densely populated urban areas,
including slums and IDP camps, are a
volatile setting for fecal–oral bacterial
transmission. On the other hand, many
populations in well-managed camps have
better access to treated drinking water
(often from a centralized, chlorinated
source) [48], adequate sanitation, and
medical care provided by humanitarian
groups. Furthermore, the density of vulner-
able populations facilitates case detection
and rapid distribution of interventions,
including education, oral rehydration, and
vaccination. But not all camps are man-
aged, and even those with decent sanitation
and clean water are still temporary settle-
ments; we cannot count on humanitarian
groups to help provide these services
indefinitely.
Rural regions, where the majority of
cholera cases have been recorded, face
many delivery challenges, including large
distances between patients and treatment
centers, poor infrastructure, inadequate
transport services, and insufficient health
personnel [S18]. Me ´decins Sans Fron-
tie `res, an international nongovernmental
organization (NGO) that has provided
health care in rural Haiti for decades,
has stressed that rural communities are at
high risk of recurrent cholera outbreaks
[49]. Scaled-up case finding and treatment
are needed to ensure rapid access to care
in rural areas [47,50].
Human Resources for Health:
Community Health Workers as a
Cornerstone of Care
One of the greatest obstacles to the
effective delivery of health services in Haiti
is the lack of health personnel. Haiti faced
a shortage of health care workers prior to
the cholera epidemic, and in early De-
cember 2010, PAHO called for an addi-
tional 350 doctors, 2,000 nurses, 2,200
support staff, and 30,000 community
health workers (CHWs) to respond to the
outbreak [51]. Encouraging gains have
been made: the CDC has worked closely
with the MSPP, ICDDR,B, and PAHO,
for example, on a train-the-trainers pro-
gram to teach health workers to prevent,
identify, and treat cholera [52,53]. ‘‘Mas-
ter trainers’’ who have graduated from this
program are assigned to departments to
train other health staff at cholera treat-
ment sites [S19] [12]. By the end of 2010,
programs had been completed in nine of
Haiti’s ten departments, producing more
than 500 graduates [54].
As the epidemic lingers in Haiti, CHWs
should be the main line of defense against
case resurgence. CHWs have been an
integral part of effective community-based
tuberculosis and HIV/AIDS prevention
and care in Haiti [55]. They can be
trained to diagnose cholera and initiate
treatment (especially ORS) in situ, includ-
ing in rural areas [20]. For example, the
ICDDR,B’s Cholera Outbreak Training
and Shigellosis Program in Bangladesh
demonstrated that CHWs can effectively
administer ORS [56]. ICDDR,B materials
are now available in Haitian Creole.
Training initiatives have contributed to
declining incidence and case-fatality rates.
Cholera management skills must now be
integrated into the regular training pack-
age for all health workers.
GOAL 2. Strengthen Water and
Sanitation Systems
A History of Water Insecurity
The cholera epidemic is a symptom of
Haiti’s long history of water insecurity.
Although some NGOs have put re-
sources into local water projects over the
years, private projects cannot replace a
robust public sector water system [S20].
But political instability and crippling debt,
among other factors, have kept the
Haitian government from providing a safe
supply of drinking water for its citizens.
Almost a decade before the 2010 earth-
quake, Haiti was ranked last of 147
countries on the Water Poverty Index (a
measure of water security) [4,5,57] and
101st out of 122 countries for water
quality [58]. The percentage of Haitians
with access to safe drinking water actually
decreased 7% between 1990 and 2005
[59]; only 30% had access in 2004 [S21]
[60]. The lack of modern sanitation
further aggravates the situation: only
27% of the country had basic sewage in
2004 [61,62]. Such underdevelopment
fuels a vicious cycle of poverty, poor
sanitation, water contamination, and ill
health [S22] [59,63,64].
Haiti’s fragile water infrastructure re-
ceived another blow in the January 2010
earthquake. One month after the out-
break, 521 of 1,356 IDP camps listed by
the United Nations (UN) shelter cluster
had no water or sanitation services [20].
However, progress has been made: by the
end of February 2011, IDP residents had
an average of 17 liters of potable water per
person per day, exceeding the Sphere
Project 15-liter standard (unpublished
2011 data from the CDC) [65,66]. This
promising trend must be continued, and
we must remain alert to disparities of
access among and within camps. For
example, some have suggested charging
for drinking water within informal settle-
ments and IDP camps on the grounds that
free water distribution—a service that has
been available in most camps, and one of
the principal reasons why they have had
low incidence of cholera—is not sustain-
able. A cost-recovery mechanism requir-
ing payment for access was instead
recommended [27]. But camp-dwellers
have little (if any) income, most of which
goes toward food and other basic needs.
Anyone who has worked with Haiti’s
urban or rural poor would predict that
this brand of ‘‘cost-recovery’’—shifting the
burden of payment onto the poorest
people—will lead camp-dwellers to look
elsewhere for water; but in post-earth-
quake Haiti, most other sources are not
clean or cholera-free [59,67].
Water Treatment Systems
Current efforts to prevent transmission
of cholera in Haiti must be continued at
the same time that treatment and filtration
systems at public water sources are
strengthened in the long term. In the
short term, point-of-use treatment and
filtration technologies should also be rolled
out to improve im-
mediate access to clean water on a
household level. Furthermore, working in
conjunction with DINEPA and the Min-
iste `re des Travaux Publics Transports et
Communications (MTPTC, Ministry of
Public Works and Communication) would
allow NGO projects to build the capacity
of municipal water systems and therefore
improve Haiti’s long-term water security.
On the health provider end, ORS must
be prepared and stored in sanitary condi-
tions or it can do more harm than good.
One study in Guinea-Bissau found that
ORS prepared in an open tub was highly
susceptible to bacterial contamination.
Storing ORS in a narrow-mouthed spigot
container and rinsing vessels with chlori-
nated water reduced such contamination
[S23] [68]. Health workers at treatment
sites across the country must have access
to guidelines based on these findings.
On the household end, point-of-use water
purification tools can help prevent diarrheal
illness, even in settings of poverty and water
insecurity. For example, household water
treatment and safe storage (HWTS) tech-
nologies offer families an independent
means of water treatment and storage, and
they have been shown to reduce waterborne
disease transmission—even during epidem-
ics. Studies estimate 30%–40% reductions
in diarrheal disease due to improved
household drinking water quality at the
point of use [S24] [69,70]. The 2002 World
Health Report highlights HWTS as the
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ing diarrheal disease in a range of contexts
[71]. Although sometimes construed as em-
ergency interventions, point-of-use water
treatment systems have also been found to
contribute to long-term reductions in water-
borne disease incidence [72].
Boiling and solar disinfection can be
difficult to deliver in Haiti due to high
costs and infrastructural constraints. Point-
of-use filtration/disinfection units and
sachets combining flocculation (physical
filtration), chlorination, and safe storage
are affordable, deliverable in resource-
poor areas, and produce enough safe
water for multiple households [S25] [73–
76]. Flocculation-disinfectant powder sa-
chets, which cost less than US$10 per year
in most cases [S26] [77], have also proved
useful in resource-poor settings [S27]
[74,78], though turbid water reduces their
efficacy [S28]. Simple cloth filtration,
shown to reduce waterborne disease trans-
mission by up to 48% [S29] [79], can
supplement sachet-based treatment to
further decrease the likelihood of V. cholerae
contamination [73].
Although household-based purification
systems should be deployed widely,
strengthening Haiti’s public water system
remains the best way to improve water
security in the long term. As noted, 70% of
Haiti’s population lacked access to potable
water before the earthquake [60]. But
even this statistic may overstate access to
improved water sources in Haiti because
public systems are rarely available year
round. The World Bank concluded that
‘‘in almost all urban areas water supply is
intermittent’’; in rural areas, supply is
equally unpredictable, particularly during
the dry season [80]. The lower Artibonite
city of Saint-Marc offers one example of a
public water system that, although long
weakened, has been improved in recent
years thanks to international and private
sector collaboration (Dr. Charles Patrick
Almazor and Inter-American Develop-
ment Bank staff, personal communica-
tion). Only robust municipal water systems
that are maintained and monitored by the
MTPTC would safeguard access to clean
water across Haiti.
Some have suggested that household-
based interventions are more effective at
preventing diarrheal disease than inter-
ventions at the source [S30] [70,74,81].
However, this is not an either/or scenario:
both improved purification technologies
within households and strengthening mu-
nicipal water systems are essential compo-
nents of water treatment. Support from
NGOs and other international groups is
needed in both the short- and long-term,
but all such efforts must be coordinated by
the MTPTC to develop the infrastructure
and capacity of the public water system.
Sanitation Tools
As noted, close patient contacts (in
slums, IDP camps, prisons, households,
and treatment sites, for example) are at
particularly high risk of infection because
of the hyperinfectious state exhibited by V.
cholerae in excrement [42,82,83]. Though
the lack of modern sanitation is a principal
cause of fecal–oral bacterial transmission,
few substantial sanitation projects have
been launched in Haiti. At least four steps
are needed to strengthen Haiti’s sanitation
system in the long term: systematic hand-
washing with soap, improvement and
installation of modern sewage systems
and latrines, integration of waste monitor-
ing with water surveillance, and improve-
ment of cadaver management.
First, hand-washing with soap can
decrease the risk of contracting most
diarrheal diseases [S31] [84]. The WHO
emphasizes that systematic hand-washing
with soap before eating and handling food
and after defecation remains one of the
surest ways to prevent cholera transmis-
sion [85]. Studies estimate that proper
hand-washing can reduce the risk of
diarrheal illness by up to 47% [86]. Yet
while soap costs about US$0.50 in Haiti,
most Haitians live on less than US$1.25
per day, most of which goes towards basic
needs such as food [87]. In the first
months of the epidemic, the UN Office
for the Coordination of Humanitarian
Affairs (OCHA) estimated that 11,000
bars of soap would be necessary to cover
certain priority IDP camps for 2 weeks
[88]. However, 2 months after the onset
of the epidemic, the UN shelter cluster
response teams reported significant short-
ages of needed materials, including soap,
water, purification tablets, and latrines
[89]. More recently, OCHA projected
that 4.5 million Haitians (3 million in the
30 main cities and towns and 1.5 million
in rural areas) would benefit from WASH
programs, and the low incidence of disease
in the IDP camps is, in part, a testament to
these efforts [89]. Nonetheless, soap dis-
tribution and hand-washing education
efforts should be scaled up in vulnerable
rural and urban areas.
Second, better sewage systems and
latrines would help curb cholera trans-
mission. Pit latrines are a good option for
rural areas, as they would strengthen
sanitation infrastructure. In the crowded
and concrete streets of Port-au-Prince,
above-ground sewage tanks are the best
available short-term solution. As part of
the city’s reconstruction, however, per-
manent underground sewage systems
must be put in place to decrease the
likelihood of fecal–water contamination
and transmission of waterborne disease
[S32] [90].
Third, waste monitoring can decrease
the spread of waterborne disease and also
improve outbreak prediction. A study in
Peru found that waste and water surveil-
lance—including weekly sewage analysis
for V. cholerae O1 and vibriophages—
signaled a cholera outbreak 1 month in
advance, facilitating the rapid implemen-
tation of prevention measures [S33] [91].
A similar approach should be explored in
Haiti in conjunction with the MTPTC.
Fourth, safe disposal of cadavers must
also be integrated into the broader waste
management system. Cadaver manage-
ment poses many challenges, including
honoring cultural practices related to
dying and death, disinfecting cadavers,
and identifying burial sites that are
acceptable to the community and will
not contaminate the waterbed [S34] [92].
Stigma also prevents effective cadaver
management: many funeral parlors refuse
cadavers from patients who died of
cholera, for example. Some efforts are
underway to develop best practices for the
safe disposal of cadavers. Organizations
like the Haitian Group for the Study of
Kaposi’s Sarcoma and Opportunistic In-
fections (GHESKIO) are training funeral
parlor staff to decontaminate and handle
cadavers. Similar initiatives addressing the
safe disposal of cadavers would help curb
the spread of cholera in Haiti.
GOAL 3. Link Prevention to
Care
Vaccination: a Pillar of Prevention
The existing arsenal of tools for effective
treatment (from rehydration to antibiotics)
and prevention (from improved sanitation
to oral vaccines) should be delivered in the
context of comprehensive care to strength-
en Haiti’s health system. As incidence
declines, long-term prevention measures,
including rolling out vaccination cam-
paigns and strengthening water and sani-
tation infrastructure, should be implement-
ed. But prevention should not come at the
expense of acute care: the biggest priorities
remain case finding and treatment. Rather,
additional resources should be secured so
that immunologically naı ¨ve populations
can be vaccinated while acutely ill patients
are being treated.
Past epidemics have been curbed with-
out vaccines, but we believe that vaccina-
tion has a significant role to play in Haiti
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quake health, water, and sanitation sys-
tems and the observed virulence of the El
Tor strain. Any rational vaccine strategy
must be coordinated by local authorities.
However, the MSPP is currently wary of
NGOs haphazardly delivering vaccine
because uneven access could trigger social
frictions and interfere with other cholera
prevention and treatment efforts. The
MSPP has called for nothing less than a
universal vaccination campaign—an end
goal this document endorses.
If sufficient vaccine and resources were
mobilized, large-scale immunization could
bring a more rapid end to the current
epidemic and help prevent a resurgence of
cases. However, there is insufficient vac-
cine currently available to cover the 10
million people in Haiti (20 million doses); a
scale-up strategy that first targets vulner-
able groups (like children under 5) is
needed. Antiretroviral therapy roll-out in
Haiti showed that pilot projects demon-
strating the utility of an intervention can
boost consensus, political will, resources,
and manufacturing for that intervention.
Pilot vaccination projects for cholera could
do the same.
Recent estimates suggest that 4 million
vaccine doses could be available by March
2012, and this figure will only increase as
implementation begins (Pan-American
Health Organization, Cholera Update
Conference Call, February 8, 2011, un-
published data). Indeed, in November
2010, experts estimated 200,000–400,000
doses could be available in 1 year; by early
February 2011, they estimated 4 million
[S35] [93]. A universal vaccination cam-
paign would require a strategy for timing,
coverage, procurement, and the mass
action effects of vaccination. Further,
scaling up efforts in Haiti would build
momentum toward a global stockpile to
prevent similar shortages during future
outbreaks [94]. Finally, this strategy
should include new research on live
attenuated vaccines that would confer
rapid and long-lived immunity after a
single dose (instead of the two doses that
existing vaccines require). Such research
should not, however, come at the expense
of implementation of current vaccines and
other components of cholera treatment
and prevention; it should be construed as
an important part of a comprehensive and
long-term response to cholera.
Concerns about the cost-effectiveness
and feasibility of implementation have
hindered progress on vaccination in Haiti,
but these concerns are fading [95]. As with
therapeutics for AIDS and multidrug-
resistant tuberculosis, the costs of cholera
vaccines vary enormously; hence, confi-
dent claims about cost-effectiveness should
be closely examined [S36] [25,96]. Imple-
mentation bottlenecks are also surmount-
able: Zanmi Lasante (Partners In Health’s
sister organization) achieved a 76% com-
pletion rate for a three-dose course of
HPV vaccine in rural Haiti, and the
earthquake occurred between the second
and third dose for many of the girls
enrolled [S37] [97]. This is almost twice
the rate of completion for similar courses
in US settings [S38] [98]. Mass two-dose
oral cholera vaccination was shown to be
feasible in Sudanese refugee camps [S39]
[99]. While refugee camps in Sudan pose
different management challenges than
IDP camps in Port-au-Prince, such vacci-
nation campaigns are an important prece-
dent and should be examined for lessons
that may pertain to Haiti.
There are two oral cholera vaccines on
the market, both feasible for use in Haiti.
Dukoral, produced by Crucell and licensed
in over 60 countries, contains recombinant
cholera B subunit, which stimulates anti-
toxic and antibacterial immunity [S40]
[25]. Dukoral has been shown to have
roughly 85% protective efficacy among
two-dose recipients (over 6 months) in
Bangladesh andPeru[100–102] andconfer
protection up to 3 years following vaccina-
tion [S41] [103]. Limited data exists on its
use in non-endemic zones, but two to three
doses appear to be effective [25].
A closely related bivalent oral cholera
vaccine is licensed as Shanchol in India
and mORCVAX in Vietnam. The latter is
produced by VaBiotech and currently
intended for domestic use in Vietnam,
while Shantha Biotechnics (acquired by
Sanofi-Aventis) is applying for WHO
prequalification to produce Shanchol for
international use. (It is already licensed
and commercially available in India.) A 5-
year efficacy trial in Kolkata, India, is
ongoing, but an interim analysis after 2
years indicated an overall protective effi-
cacy of 67% against culture-confirmed
cholera among those who received two
doses [S42] [25,104].
These vaccines have been shown to be
effective at preventing both El Tor cholera
in endemic settings and the newly emer-
gent El Tor hybrid strains, with protective
immunity expected to begin about 1 week
after the last dose [S43] [25,102,105–107].
Observed herd immunity effects (with
vaccine coverage rates of 50%) suggest
that conventional studies may yield artifi-
cially low efficacy estimates [108]. Studies
that take herd immunity into account have
found cholera vaccination in endemic
countries to be cost-effective [S44] [109].
One study in Bangladesh found a dramat-
ic reduction in cholera incidence after
widespread vaccination [96]. Mathemati-
cal models predict more substantial bene-
fits: one projected that vaccinating just
over 50% of the population would lead to
a 93% reduction in cholera incidence
[S45] [110]; another (published in 2011)
projected that 30% coverage would lead to
a 55% reduction [111]. Recent scholar-
ship also points to the significant value of
reactive (or delayed) vaccine use. A recent
case-control study in Hanoi, Vietnam,
found a protective efficacy of 76% with
reactive use of oral cholera vaccine [112].
Another recent paper suggested that, if
widespread vaccination had been
launched during epidemics over the last
decade, 40% of cases and deaths could
have been averted [113]. Although the
model does not take the benefits of herd
immunity into account, it predicts that
reactive cholera vaccination campaigns
with 50% coverage would alone have
prevented over 10,000 cholera cases in
the Zimbabwe epidemic of 2008 and
2009.
Dukoral is manufactured at a cost of
US$6 per dose and has a retail price in
North America of US$50 to US$75 per
dose [114]; Shanchol is manufactured for
less than one-third of the cost of Dukoral
[114] and is available to developing
countries through the public sector at less
than US$2 per dose [115]. Large pur-
chases, advance orders, pooled procure-
ment, and other market-based strategies
could significantly reduce vaccine cost
[S46] [114]. An immunization campaign
in Vietnam estimated the cost of a
complete mORCVAX series (a bivalent
vaccine related to Shanchol), including
delivery, at only US$0.89 per person
[S47] [107].
While there are currently fewer than
400,000 vaccine doses ready for shipment
from their manufacturers [115], advance
purchase commitments could increase
availability to several million. Past experi-
ence underscores the value of publicly
ensured purchases [S48]. For example, a
demand-side approach to bring a late-
stage pneumococcal vaccine to market for
use in sub-Saharan Africa and Asia
involved an advance market commitment
led by the Global Alliance for Vaccines
and Immunisation (GAVI). Such funding
boosted production, lowered prices, and
expanded vaccine access in these regions
[116,117]. Economies of scale also con-
tribute to lower production costs, as
observed during the scale up of antiretro-
viral therapy for AIDS and drugs for other
large-scale treatment efforts [118]. All of
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global stockpile of cholera vaccines.
Models suggest that vaccination cam-
paigns that target vulnerable populations
(such as immunologically naı ¨ve groups
living in crowded conditions with limited
access to clean water) can be equally cost-
effective as other prevention methods
[119]. Existing water and sanitation efforts
have helped keep urban cholera rates low
and should be continued and scaled up—
but not to the exclusion of vaccine
delivery. Both robust water systems and
vaccination are needed to prevent case
resurgence. Vaccination could also help
cut costs by limiting the need for future
antibiotic use [120].
Finally, existing vaccination and treat-
ment delivery channels provide an infra-
structure for cholera vaccine administra-
tion. Unlike more complex medical
interventions, oral vaccines can be imple-
mented rapidly and effectively by CHWs.
A cholera vaccination campaign could
therefore leverage existing health worker
networks without taking doctors and
nurses away from the provision of acute
care [S49] [98].
We recognize that there is insufficient
vaccine today for an immediate mass
campaign, and that the current epidemic
could be curbed before such a supply
becomes available. Without significant
investment in Haiti’s weakened health
system, there will continue to be insuffi-
cient human and financial resources to
deliver a mass vaccination campaign.
Nonetheless, we believe a rational vaccine
strategy should be pursued immediately.
Although the 1 million doses available
would provide a complete vaccine course
to only 500,000 people (about 5% of
Haiti’s population), targeting vulnerable
populations could help to reduce trans-
mission, decrease the likelihood of resur-
gence, and put gears in motion toward
amassing a global stockpile—an outcome
that would be beneficial for this epidemic
and the next.
Education and Behavioral Change:
Necessary but Insufficient
Coupling community education about
cholera transmission with the provision of
necessary supplies could improve hygienic
behavior and reduce social stigma. Numer-
ous public education campaigns have dis-
seminated information about cholera trans-
mission, diagnosis, and treatment, including
the location of treatment sites and transport
options. These efforts have targeted popula-
tions in slums, IDP camps, schools, and
other public fora, urban and rural, around
the country. In the first 2 months of the
epidemic, camp management teams imple-
mented 670 cholera risk-reduction activities
in IDP camps and their surrounding
communities; UN education cluster partners
distributed cholera prevention and water
treatment protocols in schools across the
country; phone companies, along with the
International Federation of the Red Cross
and Red Crescent Societies, the Interna-
tional Organization for Migration, and
others, sent public health warnings via
SMS; and radio stations dedicated broad-
casts to education programs, provided
updates from the MSPP, and answered
caller questions [89]. All of these efforts
should continue to be implemented thr-
oughout the country.
Yet the success of these efforts has been
limited. Surveys to assess IDP camp
residents’ awareness of cholera manage-
ment protocols—where to access clean
water, obtain ORS, and dispose of cadav-
ers—reveal serious gaps, particularly con-
cerning where to obtain ORS. Continued
surveillance of education programs could
help improve message targeting and effi-
cacy [89].
The more important reason for the
failure of education and behavioral cam-
paigns is that, like other diseases of
poverty, cholera’s spread is dictated less
by bad behavior than by a chronic
shortage of tools and resources. People
may defecate near public water supplies if
they lack decent sanitation and sewage
systems; they may draw water from
contaminated sources if there is no
alternative; and they may not wash their
hands if soap is too expensive or inacces-
sible. The structures of poverty mediate
risk of cholera infection, and therefore
information can only keep cholera at bay if
vulnerable populations are furnished with
necessary resources and supplies.
As noted, proper hand-washing can
significantly reduce transmission of chol-
era and other waterborne diseases. Yet
without adequate access to soap and clean
water, public health messages about hand-
washing are futile. As late as December 7,
2010, UN officials reported soap shortages
in IDP camps, urban slums, and rural
communities [89]. Therefore, education
and behavioral change campaigns must be
linked with distribution efforts to make
prevention and treatment tools available
to all those receiving public health mes-
sages. Progress on this front is underway.
Oxfam, for example, is using former
immunization points—locations familiar
to the public—to distribute soap and
ORS and to conduct hand-washing and
prevention programs. It has brought 40
local organizations into its fold an aims to
reach 340,000 beneficiaries with this
strategy [89].
Public health messaging has also sought
to address cholera-related stigma. Health
workers have encountered resistance to
building treatment sites because local
residents fear that these facilities could
bring cholera to the community. OCHA
and many Haitian media groups have
reported lynchings of individuals thought
to have used witchcraft to spread cholera
[S50] [89,121]. Stigma is, in part, tied to
ignorance about disease etiology, trans-
mission, prevention, and treatment. But it
is equally tied to an absence of tools to
control the disease: there was great stigma
about AIDS in Haiti until access to
antiretroviral treatment transformed the
disease from a death sentence into a
chronic, manageable condition [55,122,
123]. The same is likely true for cholera.
Behavioral and education efforts must
therefore be linked to a flow of resources
and medical supplies to be effective.
Building a Feedback Loop: Sur-
veillance and Monitoring
Laudable efforts are underway to collect
and compile surveillance data on the
national level and to map health facilities
and care capacity. But these efforts must be
expanded to avoid a resurgence in cases in
the coming months and years. Haiti’s
existing national sur-
veillance system regularly aggregates report-
ed case data: local MSPP officials send
hospital and clinic case counts to central
authorities who aggregate and transmit the
information to the central government; the
MSPP then posts all non-hospitalized and
hospitalized cases daily
on a public Web site [12]. In addition,
geographic information systems (GIS) and
basic capacity data have been used to map
treatment sites across the country. Reliable
data regarding treatment availability (and
lack thereof) would improve the delivery of
cholera care [89].
Additional sentinel sites and greater
resources for surveillance efforts could help
anticipate, treat, and prevent the further
spread of cholera and other preventable
diseases. Surveillance is a key part of
treatment and prevention, and simple but
effective models exist. For example, a four-
symptom diagnostic method (diarrhea,
fever, cough, skin rash) has helped identify
transmissible diseases in one IDP camp
[S51] [124]. Robust individual case data
also illuminates new information about
epidemiology, prevention and treatment
efficacy, and the differential vulnerability of
populations. Surveillance enables treat-
ment experiences to drive prevention
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of limited resources.
That the country’s early warning system
was able to rapidly detect the first cases of
cholera highlights the strong leadership of
the MSPP, PAHO, and the CDC. How-
ever, some have suggested that cases are
being underreported, particularly in rural
areas. For example, many children die
before they reach treatment sites, and
therefore their deaths may not be captured
by current monitoring techniques (Dr.
Jean-William Pape, personal communica-
tion). Poor coordination among health
providers has further hindered the MSPP’s
case data collection [6]. To supplement
the existing reporting system, mathemati-
cal models can be useful for understanding
the changing nature of disease distribution
[S52] [125,126].
Cholera is likely to become endemic in
Haiti, and it presents a threat to other
countries in the region and around the
world. Surveillance must be part of a
comprehensive response to the immediate
epidemicandacornerstoneofthecountry’s
health infrastructure. Education, supply
chain, treatment, and prevention channels
can be coordinated to feed information to a
central source; early results of antibiotic
scale-up and vaccine pilots should guide
future implementation; the MSPP should
coordinate all monitoring to strengthen its
national surveillance systems for cholera
and other notifiable diseases.
Conclusion. Rapid
Implementation and the Road
to Health Systems
Strengthening
The comprehensive, integrated strategy
described in this document should be
implemented to mitigate the current
cholera epidemic and strengthen the
Haitian health system in the long term.
Scaled-up delivery of ORS, intravenous
therapy, antibiotics, vaccine, soap, and
other tools for cholera prevention and care
should be linked to the provision of
primary health care services to strengthen
supply chains countrywide. CTCs, CTUs,
ORPs, and other cholera-specific facilities
and infrastructure should be integrated
into the public health system. We can
build on the extensive national HIV
treatment network to establish permanent
cholera treatment sites at hospitals and
health centers. Cholera caregivers should
also be trained to identify and treat other
diarrheal diseases and illnesses of poverty.
In other words, cholera-specific interven-
tions should be used as a wedge to bolster
primary health care services and strength-
en the Haitian health system.
Towards an Implementation Plan
The Haitian government must lead the
ongoing response to cholera in order to
promote collaboration between the mul-
tiplicity of donors, aid groups, and NGOs
offering assistance in Haiti—all of which
have disparate protocols and goals. Even
with the best intentions, these groups can
impose significant burdens on a stressed
public health system. Only a well-coordi-
nated response with clear leadership from
the MSPP and DINEPA will be able to
address the acute challenges of the current
outbreak while also building robust health,
water, and sanitation systems to prepare
for future epidemics.
The goal of this paper is to highlight the
priorities of a comprehensive, integrated,
and long-term cholera response; the next
and even more important goal is the
implementation of this strategy. Imple-
mentation will require political will and
substantial, long-term financial commit-
ments from global health authorities,
donors, and health providers. In a De-
cember 2010 report to the UN General
Assembly, Secretary-General Ban Ki-
moon asked nations to help Haiti respond
to the cholera epidemic [S53] [127]. As of
February 4, 2011, only 45% of the
US$175 million appeal had been met
[45]. Haiti needs long-term financial
support or it will still be vulnerable when
the next epidemic—of cholera or another
preventable disease—strikes.
A Call for Consensus and Action
The months following the earthquake
on January 12, 2010, were among the
most trying in Haiti’s history. Continued
international assistance can prevent suf-
fering and death in the near term and
help Haiti to rebuild better in the long
term. But the response to cholera must be
comprehensive, linking prevention to care
and coordinating Haitian and non-Hai-
tian partners. In the last two decades, a
period of economic stagnation and fre-
quent political turmoil, comprehensive
and integrated community-based preven-
tion and care reduced infant mortality
rates in Haiti by two-thirds and cut the
AIDS epidemic in half. This model has
since been adopted across the developing
world. We have the opportunity to do the
same with cholera.
Debates about prevention versus care
are misguided. We must integrate popula-
tion-based prevention measures with med-
ical treatment to contain the outbreak and
save thousands of lives. Haiti faces both
urgent and entrenched challenges that
require solutions combining speed in
the short-term and sustainability in the
long-term.
Our objectives in Haiti should be no
different than those we would set in the
Dominican Republic, the United States,
or any other neighboring country. This
‘‘Haitian’’ epidemic is part of a global
pandemic that claims over 100,000 lives
each year. The presence of cholera in
Haiti highlights the volatility of trans-
mission in an era of global migration
and trade, and it threatens to spread the
pathogen in the Caribbean and across
the Western Hemisphere. All nations
share a common interest in eliminating
cholera wherever it occurs: a world in
which the burden of cholera follows the
burden of poverty is not just inequitable,
it is dangerous, even to rich nations.
We, a group of 44 medical and public
health researchers, policymakers, fun-
ders, and practitioners, working for re-
search universities, government agencies,
NGOs, international multilateral organi-
zations, and the private sector in Haiti,
the US, and many other countries around
the world, strongly support a compre-
hensive, integrated, and long-term re-
sponse to cholera in Haiti. We stand
behind the government of Haiti and are
committed to helping implement this
strategy together and in the months and
years ahead.
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